These three-week-old cells represent a breakthrough in blood transfusion for patients with blood diseases like sickle cell disease and individuals with rare blood species for whom finding suitable donor blood may be challenging.
According to the Independent, artificial blood cells were created in a lab using stem cells from donors and then distributed to volunteers in amounts ranging from 5 to 10 millimetres.
Because processed blood cells are more advanced than given red blood cells, scientists anticipate that they will perform better than the latter. As a result, patients who require blood frequently may have fewer blood transfusions.
According to Ashley Toy, a professor of cell biology at the University of Bristol and the Director of Blood Unit and the transplant of red cell products at the National Institute for Human Rights, “this challenging and exciting experience is a huge starting point for blood manufacturing from stem cells.”
Cedric Givet, a professor of blood transfusion and blood diseases consultant at Cambridge University, stated, “We believe that the red blood cells planted in our laboratory will continue for a longer period of time than those that originate from blood donors.”
“If our experience, which is the first of its kind in the world, is any indication, patients who currently require long-term, routine blood transfusions will eventually require fewer transfers, which helps to change their care,” he concluded.
”
This groundbreaking study has made significant advancements in the production of red blood cells, which can be used to safely provide blood to patients with diseases like sickle cells.
The vast majority of blood will continue to be obtained organically through blood donation, but it is necessary to consider the likelihood of blood transfusion patients from this work.
A technological miracle The success of experiences on the first industrial blood in history
About Author
